UNIQUE SEQUENCES
Results
Showing up to 25 records.
| Peptide ID | Sequence | Length | Status | Functions |
|---|---|---|---|---|
| MYP_022126 | MKLVLKNKLVFSLIFLLTFTSCSIIKFPFKAVKKVSKSTAIKKNKSVQLERFLRNMSSDERKKWYIKTYSKIATDQMKKYKIPASIILAQGLVESGAGASNLALKSNNHFGIKCHQEWRGKKVYHDDDKKNECFRKYKNPIESYKDHSEFLTTRGRYSFLFRLPIKDYVGWSEGLSKAGYATDPKYPEKLINVIERYNLWKYDGSKKQKTKIKNKKKINDDSNYTVKKGDTLYSISKKHKISVDDIMKKNNLKNNNLIIGQKLKI |
265 | Standard |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal
|
| MYP_022127 | MKVVIFIFALLATICAAFAYVPLPNIPQPGRRPFPTFPGQGPFNPKIKWPQGY |
53 | Standard |
Antimicrobial
|
| MYP_022128 | MALTRFHLLSDEEYNNARLLFLSIAEGTREYPYLDTDIARANPTIGIGFNLAVETVLTAVLKDFGFDFDQPDPNNQNEKFQHAIDVKSQKDIHKIVTKYYSPSSLHDHPQNGTLRTNLDKIMTDRVTEMGKKSLGTEGAKTSFAYDSLEEMQGAFNSIVKTYETKLDIWLSGQKKGGFPGNLSKTNIGPVPFSRERIALFSLAFNTKDGKT |
211 | Standard |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal
|
| MYP_022129 | TSFSEYWSLLSALAAYAP |
18 | Standard |
Anticancer
|
| MYP_022130 | FHKHGHGHGKHKNKGKKN |
18 | Standard |
Antimicrobial
|
| MYP_022131 | RLARAGLAQ |
9 | Standard |
Anti-inflammatory, COX-1 Inhibitory, COX-2 Inhibitory, Lipoxygenase Inhibitory, Antidiabetic, Alpha-amylase inhibitory, Metabolic Syndrome, Pancreatic lipase inhibitory
|
| MYP_022132 | MNFYKIFIFVALILAISIGQSEAGWLKKLGKRIERVGQHTRDATIQGLGIAQQAANVAATARG |
63 | Standard |
Antibiotic, Antimicrobial, Non-hemolytic, Non-ribosomal
|
| MYP_022133 | FWPGLILKGLGAL |
13 | Standard |
Antimicrobial, Anticancer
|
| MYP_022134 | GKVWDWIKKTAKDVLNSDVAKQLKNKALNAAKNFVAEKIGATPSEAGQMPFDEFMDILHYY |
61 | Standard |
Antibiotic, Antimicrobial, Antifungal, Fungicide, Anti-Gram-negative, Anti-Gram-positive, Cytolytic, Hemolytic, Non-ribosomal
|
| MYP_022135 | YGGFL |
5 | Standard |
Opioid, Analgesic, Neuromodulator, Pronociceptive, Neuropeptide, Receptor modulation, DPP-III Inhibitory, opioid neuropeptide precursor family, Growth factor signaling, Hormone, Neuropeptide signaling, Physiological regulation, Behavior regulation, Endocrine, Antioxidant, Agonist, Cell-Cell Communication, Drug Delivery Vehicle, Blood-Brain Barrier, Neurotransmitter, Nociception regulating peptide
|
| MYP_022136 | MKINQIIAKKLAAYGLSGALILAGAGTVSFYEGKANKVYVDPVGILTSCFGHTGRELKKGQTFTDDQCLQQLAEDLVAHDNGMMKYVRVPLSDKEHAAYLSFTYNLGVNAFANSTLLKKLNKEDRVGACNELLRWDKAKGKTLAGLTKRRQDENKLCLEGVLERVDENYK |
170 | Standard |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase, Cytolytic, Non-hemolytic
|
| MYP_022137 | MARISAEQAGGKNRIAFLDMIAHSEGTVHDPATKDDGYDVLVTGVNGPQRFSSYADHPNVLVTINHNGLKSTAAGRYQLLHRFWQPYKTILKLPDFSPVSQDLVALQQIRERGALQYIDEGMFDEAVRACSNIWASLPGNDYGQRQNSVAVLLTAYQAAGGTATATA |
167 | Standard |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase
|
| MYP_022138 | FFSASCVPCADGKQYPNLCELCSGTGENKCA |
31 | Standard |
-
|
| MYP_022139 | IPCAESCVWIPCTVTKMLGCSCKDKVCYNS |
30 | Standard |
-
|
| MYP_022140 | GGGGGGGSGYVGKHEGNGGAQGQGSGGGGGGGGGGGGGGSGQGSGSGYGYGYGKGGGGGGGGGGGMARKVIALAFLLLLTISLSKSNAARVIKYNGGGSGGGGGGGGGGGGGGNGSGSGSGYGYGYGKAGGQSGGGQGSGGGGGGGGGGGNGSGSGSGYGYGYGQ |
165 | Standard |
Signaling
|
| MYP_022141 | MKIYVFALLVMAAVAFARQLPVEDLNKDEVPLDILYLPLASEDESSPVEHHRERRFTCNNNACNAHCIVRNRKGGYCNDKNLCVCRK |
87 | Standard |
Antimicrobial, Defensin, Non-hemolytic, Non-ribosomal
|
| MYP_022142 | AISCGAVTGDLSPCLTYLTGGPGPSPQCCGGVKKLLAAANTTPDRQAACNCMKSAASSITKLNTNNAAALPGKCGVNIPYKISTSTNCNTVK |
92 | Standard |
Antimicrobial, Antibacterial, Anti-Gram-negative
|
| MYP_022143 | MLRPSLTLLLLSALLFAHILVDDVSATTMTFVNKCSHPVWPGIQPSAGQPILAKGGFTLPPNKATTLHLPPLWSGRFWGRHGCAFDASGRGRCATGDCGGNLYCSGLGGTPPATLAEITLGHEQDFYDVSLVDGYNLAISITPYQGSGKCSYAGCVSDLNMMCPVGLQVRSHDNRRVVACKSACSAFNSPRYCCTGSYGSPQSCKPTAYSRIFKTACPRAYSYAYDDPTSIATCTRGNYVVTFCPRHGHR |
250 | Standard |
Antimicrobial
|
| MYP_022144 | MNFAKIFYFFFTVVVAICCVSAAPRWKGFKKIEKLGRHIRDGVVKAGPAVGVVGQASSIMG |
61 | Standard |
Antimicrobial, Non-hemolytic, Non-ribosomal
|
| MYP_022145 | MLSGMEKQPAMLLVLVTLCAFACKRSVAQSAFATFYGGKDGSGTMGGACGMSRNWGANWQSNAYLAGQSLSFIVQLDDGRKVTAWNVAPSNWFFGATYSTSWVQFTITATNLCPPNWALPSNSGGWCNPPRQHFDMSQPAWENIAVYQAGIVPVNYGNLYNAGYGLYNAALSSALFNDGAMCGACYTITCDTSQTKWCKPGGNSIYKRVPCQRSGGIRFAISGHDYFELVTVTNVGGSGVVAQMSIKGSNTGWMA |
255 | Standard |
Signaling
|
| MYP_022146 | RLLNTGLVGYENDVSRLVKVKLTQGQFDALVSFAYNLGARTLSSSTLLRKLNSGDYAGAADEFLRWNKAGGKVLNGLTRRREAERALFLS |
90 | Standard |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase
|
| MYP_022147 | GGSGEDEQFLGFGSDEEVRVR |
21 | Standard |
Protein-binding, Peptide-protein interaction, Structural binding
|
| MYP_022148 | LLAGLAANFLPTIICKIAR |
19 | Standard |
-
|
| MYP_022149 | MRRLFGIGLVCVLGFVKAQTWKTEDQYVQKFAPYAVEEMEKYKIPASITLAQGLLETGGGQSRLAQEGKNHFGIKCKEDWTGKTMKHTDDAPNECFRVYEDPKQSYEDHSVFLATRKYYTKLFDLNPKDYKAWAHGLKKAGYATNPRYAYILIDKIEKYKLYEFDNTTKDEVYYAILKLYPNLNNDAVFMAQLGQEKQNEKVAPPTVKVPYSQGSYAKKQSEVSDIVDANTKTALLKNILVKNHPNGDLKFFVMPVNADISDIAKKFGISEKRLMKYNELEDSKLAKNDIIFLEGKNSSGNKETYKAGIGETMHDIAQKFGIKLKKLYSKNRMEAGEEPRAGQVIYLQSKKPRA |
354 | Standard |
Antimicrobial, Bacteriolytic enzyme, Hydrolase, Non-hemolytic, Non-ribosomal
|
| MYP_022150 | KAFAIIDQDKSGFIEEDELKLFLQNFSAGARA |
32 | Standard |
Immunomodulatory, Allergenicity
|